Royalty Pharma PLC (RPRX)
25.80
+0.10
(+0.37%)
USD |
NASDAQ |
Nov 18, 16:00
25.80
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Total Liabilities (Quarterly): 7.784B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.784B |
| June 30, 2024 | 7.905B |
| March 31, 2024 | 6.267B |
| December 31, 2023 | 6.298B |
| September 30, 2023 | 6.270B |
| June 30, 2023 | 7.308B |
| March 31, 2023 | 7.252B |
| December 31, 2022 | 7.288B |
| September 30, 2022 | 7.256B |
| June 30, 2022 | 7.332B |
| Date | Value |
|---|---|
| March 31, 2022 | 7.237B |
| December 31, 2021 | 7.267B |
| September 30, 2021 | 7.346B |
| June 30, 2021 | 6.110B |
| March 31, 2021 | 6.077B |
| December 31, 2020 | 6.124B |
| September 30, 2020 | 6.192B |
| June 30, 2020 | 6.291B |
| March 31, 2020 | 6.209B |
| December 31, 2019 | 6.308B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.077B
Minimum
Mar 2021
7.905B
Maximum
Jun 2024
6.806B
Average
6.773B
Median
Total Liabilities (Quarterly) Benchmarks
| Geron Corp | 152.67M |
| Amicus Therapeutics Inc | 607.73M |
| Ionis Pharmaceuticals Inc | 2.419B |
| Arbutus Biopharma Corp | 33.55M |
| Syndax Pharmaceuticals Inc | 59.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.04B |
| Shareholders Equity (Quarterly) | 6.870B |
| Debt to Equity Ratio | 1.107 |
| Current Ratio | 1.536 |
| Net Debt Paydown Yield | -0.76% |